| Product Code: ETC9513454 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Hereditary Angioedema Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Hereditary Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Hereditary Angioedema Market - Industry Life Cycle |
3.4 Suriname Hereditary Angioedema Market - Porter's Five Forces |
3.5 Suriname Hereditary Angioedema Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Suriname Hereditary Angioedema Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Suriname Hereditary Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Suriname Hereditary Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about hereditary angioedema (HAE) in Suriname |
4.2.2 Growing investments in healthcare infrastructure and research for rare diseases |
4.2.3 Rising prevalence of HAE cases in the region |
4.3 Market Restraints |
4.3.1 Limited availability of advanced treatment options for HAE in Suriname |
4.3.2 High costs associated with HAE management and treatment |
4.3.3 Lack of specialized healthcare professionals with expertise in managing HAE |
5 Suriname Hereditary Angioedema Market Trends |
6 Suriname Hereditary Angioedema Market, By Types |
6.1 Suriname Hereditary Angioedema Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Suriname Hereditary Angioedema Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Suriname Hereditary Angioedema Market Revenues & Volume, By C1 Esterase Inhibitor, 2021- 2031F |
6.1.4 Suriname Hereditary Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.1.5 Suriname Hereditary Angioedema Market Revenues & Volume, By Kallikrein Inhibitor, 2021- 2031F |
6.1.6 Suriname Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Suriname Hereditary Angioedema Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Suriname Hereditary Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.3 Suriname Hereditary Angioedema Market Revenues & Volume, By Subcutaneous Injection, 2021- 2031F |
6.2.4 Suriname Hereditary Angioedema Market Revenues & Volume, By Oral, 2021- 2031F |
6.3 Suriname Hereditary Angioedema Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Suriname Hereditary Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Suriname Hereditary Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Suriname Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
7 Suriname Hereditary Angioedema Market Import-Export Trade Statistics |
7.1 Suriname Hereditary Angioedema Market Export to Major Countries |
7.2 Suriname Hereditary Angioedema Market Imports from Major Countries |
8 Suriname Hereditary Angioedema Market Key Performance Indicators |
8.1 Number of HAE awareness campaigns conducted in Suriname |
8.2 Percentage increase in healthcare funding allocated for rare diseases like HAE |
8.3 Number of HAE patients diagnosed and receiving treatment in Suriname |
9 Suriname Hereditary Angioedema Market - Opportunity Assessment |
9.1 Suriname Hereditary Angioedema Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Suriname Hereditary Angioedema Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Suriname Hereditary Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Suriname Hereditary Angioedema Market - Competitive Landscape |
10.1 Suriname Hereditary Angioedema Market Revenue Share, By Companies, 2024 |
10.2 Suriname Hereditary Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here